✦ LIBER ✦

Acute lymphoblastic leukemia: Treatment

✍ Scribed by Emil Frei Iii; Stephen E. Sallan

Publisher: John Wiley and Sons
Year: 1978
Tongue: English
Weight: 873 KB
Volume: 42
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197808)42:2+<828::aid-cncr2820420704>3.0.co;2-w

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acute leukemia occurring 19 years after

Acute leukemia occurring 19 years after treatment of acute lymphoblastic leukemia

✍ Eduardo E. Reynoso; Armand Keating; Dr. Michael A. Baker 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 241 KB 👁 3 views

A 22-year-old woman presented with acute lymphoblastic leukemia (ALL) during pregnancy. She had been successfully treated for ALL at the age of 3 years and had received maintenance treatment for 11 years. Complete remission of 3 years or more is an important factor for long-term survival and potenti

Treatment of acute lymphoblastic leukemi

Treatment of acute lymphoblastic leukemia in adults

✍ Prof. Tiziano Barbui; Renato Bassan; Teodoro Chisesi; Raffaele Battista; Sergio 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 276 KB

Thirty-seven adult patients with acute lymphoblastic leukemia were treated with a protocol called HEAV'D including Adriamycin, Vincristine, L-Asparaginase, Cyclophosphamide and Dexamethasone. The complete remission rate was 70 per cent. The median duration of remission was more than 30 months. Patie

Cardiorespiratory status after treatment

Cardiorespiratory status after treatment for acute lymphoblastic leukemia

✍ Turner-Gomes, Sophronia O.; Lands, Larry C.; Halton, Jacqueline; Hanning, Rhona 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 638 KB

The use of certain chemotherapeutic agents is associated with dose-related cardiotoxicity and, potentially, with restrictive lung disease. Therefore, we assessed the cardiopulmonary status and exercise capacity of 19 patients (pts; 9M:lOF) 1.1 to 7.1 years (mean 4.6 2 1.5 years) after successful tre

Unexpected pancytopenia following treatm

Unexpected pancytopenia following treatment of acute lymphoblastic leukemia

✍ Andrew Innes; Philippa C. May; Jiří Pavlů; Barbara J. Bain 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 484 KB 👁 2 views

Incidence of secondary acute myelogenous

Incidence of secondary acute myelogenous leukemia after treatment of childhood acute lymphoblastic leukemia

✍ Susan G. Kreissman; Richard D. Gelber; Harvey J. Cohen; Luis A. Clavell; Pearl L 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 580 KB

I17 Treatment of acute lymphoblastic leu

I17 Treatment of acute lymphoblastic leukemia in adults

✍ D. Hoelzer; N. G¨okbuget 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Recent treatment strategies in adult ALL mainly include (1) intensification of induction and consolidation chemotherapy, (2) molecular targeting, particularly in Ph/bcr abl pos-ALL, (3) antibody therapy and (4) extension of stem cell transplantation (SCT). New diagnostic tools are used to refine def